Validus Pharmaceuticals

CompanyUnited States

Validus Pharmaceuticals develops 2 assets, the furthest approved (Bumex in edema associated with congestive heart failure). Mostly programs acting on SLC12A1 and ADRB1; based in the United States.

2
Assets
Furthest stage: Approved; 4
Trials: 2
Signals

Pipeline

2

Bumex
Approved, SLC12A1, edema associated with congestive heart failure
Lopressor
Approved, ADRB1, myocardial infarction, acute myocardial infarction

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms4
Trials4
Signals2
Similar companies6